A 2013 study in The Oncologist found that 24% of all cancer patients chose not to fill a prescription due to cost, while about 20% filled only part of a prescription or took less than the prescribed amount. A February study published in Cancer had similar findings, with about 10% skipping medication or taking less than prescribed, and 14% delaying filling a prescription. Given that more than 1.6 million Americans are likely to be diagnosed with cancer this year, that suggests 168,000 to 405,000 ration their own prescription use.“ Patients are being harmed daily” by high treatment costs, said Dr. Hagop Kantarjian, a leukemia specialist and professor at Houston’s MD Anderson Cancer Center. “It’s causing more deaths than necessary.”
While the food we eat is undoubtedly important to supporting our health, a healthy home environment is more crucial because our homes – from the air we breathe to the products we use to clean – can actually be more toxic for us than our diet. This is why a non-toxic home cleaning approach is vitally important.
Using a new tool for editing genomes, known as CRISPR, researchers have genetically engineered immune cells and improved the ability of these cells to kill cancer cells in mice.
When patients are facing cancer treatment they are usually frightened and feeling vulnerable. However, it is vital to keep in mind that you are a consumer purchasing a very expensive service. If you have cancer, your life may depend on the choices you make, so you should be more careful than you would be in buying a house or a car.
Researchers in China have discovered that a metabolic enzyme called AKR1B1 promotes basal-like breast cancer progression. A study published in The Journal of Experimental Medicine suggests that an inhibitor of this enzyme currently used to treat diabetes patients could be an effective therapy for this frequently deadly form of cancer. Epalrestat, a drug that inhibits AKR1B1 and is approved in Japan to treat peripheral neuropathies associated with diabetes, was also able to block the growth and metastasis of human basal-like breast cancer cells. Since epalrestat is already on the market and has no major adverse side effects, our study provides a proof of principle that it could become a valuable targeted drug for the clinical treatment of basal-like breast cancer.
A Dutch study involved 62,573 women ranging in age from 55 to 69. Over a time span of 20 years, more than 3,000 of the women were diagnosed with breast cancer. The study showed that post-menopausal estrogen-receptor-negative breast cancer was 40 percent less prevalent among women who closely adhered to a Mediterranean diet, compared to those who did not. This type of cancer — which generally strikes post-menopausal women — usually does not have a very good outcome, since estrogen has no effect on tumor growth, thereby limiting treatment options.
As the costs of cancer care rise, crowdfunding is helping some patients avoid a financial crash.
“This work is novel because it is another piece of evidence to support an environmental cause of cancer,” Leary said. “While it would be premature to say these differences are attributed to Superfund sites, there does appear to be an association. More research is needed to determine what this relationship is and why it exists, but identifying that a difference exists is a necessary first step.”
As far as men go, getting guys to even consider checking their breasts regularly is no easy task. Groups like The Male Breast Cancer Coalition and HIS Cancer Awareness are changing that by sharing information and awareness for guys. Self-exams will save lives, but even that is a hard-sell where men are concerned. Though it’s a very rare disease, men with breast cancer are much more likely than women to die from it, due to our reluctance to seek help.
We’d like to believe that family and friends want to offer words of support when hearing about a new cancer diagnosis, treatment decision or prognosis, but sometimes words unintentionally cause pain.
The shift from film to digital technology appears to have improved cancer detection rates for diagnostic mammography, but also has increased the abnormal interpretation rate, which may lead to more women undergoing biopsies for benign conditions, according to a new study that appears online in the journal Radiology.
Breast cancer patients who receive the drug Herceptin for nine weeks as part of their post-surgery chemotherapy regime may enjoy better health outcomes, according to new research led by UCL, compared to those who receive it for 12 months, the period currently recommended in the English NHS. The researchers calculated that switching to the nine-week course of Herceptin could also save the NHS over £100 million a year. The study, a cost-effectiveness analysis of Herceptin, was published in the journal PLOS ONE.
Previous studies have associated an unhealthful diet – particularly one that is low in vegetables, high in refined sugar and carbohydrates, and high in red and processed meats – with chronic inflammation, which may raise the risk of certain cancers. According to the new study, it is this diet-induced inflammation that may increase a woman’s risk of breast cancer prior to menopause.
Vitamin C is up to ten times more effective at stopping cancer cell growth than pharmaceuticals such as 2-DG, according to scientists in Salford, UK. The research, published in Oncotarget, is the first evidence that Vitamin C (ascorbic acid) can be used to target and kill cancer stem cells (CSCs), the cells responsible for fuelling fatal tumours.
Some studies have linked the consumption of soy products with breast cancer. The findings have been mixed, but new research aims to settle the controversy. Soy is found to be safe and potentially even beneficial for women with a certain type of breast cancer
A new study suggests that blood platelets engineered to deliver an immunotherapy drug may effectively eliminate cancer cells missed by surgery and prevent them from forming new tumors. This targeted approach, tested only in mice so far, could potentially produce fewer side effects than traditional immunotherapy, the study team believes.
While we lead more convenient lives, our modern-day electric gadgets may be silently harming… and even killing us. It turns out they emit “dirty electricity” and electromagnetic frequencies (EMFs). Many of these frequencies are quite different to anything that exists in nature. As our environment becomes denser with man-made unnatural EMFs, our bodies are affected by these frequencies, which bring about unhealthy alterations in our body and mind and lead to disease.
HairToStay focuses on getting patients with cancer access to cooling caps so that they reduce their chance of losing their hair.
MRI screening improves early diagnosis of breast cancer in all women-not only those at high risk-according to a new study from Germany published online in the journal Radiology. MRI has long been known as an effective breast cancer screening modality that offers better sensitivity than mammography and ultrasound. Currently, guidelines reserve breast MRI screening for women who have a strong family history or other specific breast cancer risk factors. MRI screening has not been considered necessary for women at average risk, and there has been resistance to expansion of MRI into this population due, in part, to concern over higher costs.
The study found that 31.6 percent of recently diagnosed survivors (those who were diagnosed within the past two years) and 27.9 percent of patients previously diagnosed (two years ago or longer) reported a change in their prescription due to financial reasons. This is compared to 21.4 percent of people without a history of cancer.